Comparison of Subjective Refraction Measurement With SiVIEW Software and by an Expert
Study of the Subjective Refraction Measured With SiVIEW Software Compared to That Obtained Manually by an Expert. Monocentric Cross-sectional Study
1 other identifier
interventional
111
1 country
1
Brief Summary
Main objective Show that the equivalent sphere refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert. Secondary objectives Show that the sphere refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert. Show that the cylinder refraction measurements obtained by the SiVIEW software have no significant clinical difference with those obtained by an optometrist expert. Show that the visual acuity measurements obtained by the SiVIEW software do not have a significant clinical difference with those obtained by an optometrist expert. Demonstrate that the report delivered for each eye exam by SiVIEW software is consistent and relevant to a vision health practitioner. Show that the differences obtained between two eye examination experts are consistent with those found in the literature.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 30, 2019
CompletedFirst Posted
Study publicly available on registry
December 4, 2019
CompletedStudy Start
First participant enrolled
November 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2023
CompletedNovember 24, 2023
March 1, 2023
8 months
November 30, 2019
November 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Equivalent sphere measurement
The subject will have an eye exam with SiVIEW and an examination by an optometrist expert. The equivalent sphere value will be evaluated in both cases.
At time of inclusion
Secondary Outcomes (5)
Sphere measurement
At time of inclusion
Cylinder measurement
At time of inclusion
Visual acuity
At time of inclusion
Consistency and relevance of the SiVIEW report
At time of inclusion
Measurement between two optometrist experts
At time of inclusion
Study Arms (1)
Eye examination by expert and SiVIEW software
EXPERIMENTALEye examination by an expert and by a technician with the SiVIEW system.
Interventions
Eye examination by a technician with the SiVIEW software
Eye examination by an expert including optimal correction in distance and near vision
Eligibility Criteria
You may qualify if:
- subject with visual AV on each eye \>= 8/10 and no amblyopia
- subject with normal environmental transparency
- subject with a healthy fundus that does not reveal major abnormalities that may affect vision
- subject able to read the letters of the Latin alphabet
- subject without heavy drug treatment that may affect vision as synthetic antimalarials, corticosteroids
- non-diabetic subject
- non nystagmic subject
- non-strabic subject
- subject who has not had eye surgery less than 1 year old
You may not qualify if:
- subject with a topography showing an anomaly (keratoconus type or other)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- SiVIEWlead
Study Sites (1)
Ophthalmological Foundation A. de Rothschild
Paris, France
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Damien Gatinel, MD
Head of Department Ophthalmological Foundation A. de Rothschild, Paris, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 30, 2019
First Posted
December 4, 2019
Study Start
November 1, 2022
Primary Completion
June 15, 2023
Study Completion
June 15, 2023
Last Updated
November 24, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share